Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Dexamethasone - Ocular Therapeutix

Next Previous
X
Search
Drug Profile

Dexamethasone - Ocular Therapeutix

Alternative Names: Dexamethasone insert - Ocular Therapeutix; dexamethasone intracanalicular insert; Dexamethasone intracanalicular insert - Ocular Therapeutix; Dexamethasone intracanalicular plug; Dexamethasone ophthalmic insert; Dexamethasone punctal plug - Ocular Therapeutix; Dexamethasone punctum plug; DEXTENZA; Dextenza Ophthalmic Insert; OTX-DED; OTX-DP

Latest Information Update: 06 Sep 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Ocular Therapeutix
  • Developer AffaMed Therapeutics; Ocular Therapeutix
  • Class Anti-inflammatories; Antiallergics; Antiemetics; Antihyperglycaemics; Antineoplastics; Antirheumatics; Eye disorder therapies; Fluorinated steroids; Glucocorticoids; Ketones; Non-opioid analgesics; Phosphates; Pregnadienetriols; Small molecules; Sodium compounds; Vestibular disorder therapies
  • Mechanism of Action Glucocorticoid receptor agonists; Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Allergic conjunctivitis; Ocular inflammation; Ocular pain
  • Phase II Dry eyes

Most Recent Events

  • 22 May 2024 Ocular Therapeutix completes a phase II trial in Dry eyes in the USA (Ophthalmic) (NCT05814757)
  • 19 Feb 2024 Preregistration for Allergic conjunctivitis in Singapore (Ophthalmic)
  • 19 Feb 2024 Preregistration for Ocular inflammation in Singapore (Ophthalmic)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top